Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
An alternative sterility assessment for parenteral drug products using isothermal microcalorimetry
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4211096
Author(s) Brueckner, David; Krähenbühl, Stephan; Zuber, Ulrich; Bonkat, Gernot; Braissant, Olivier
Author(s) at UniBasel Krähenbühl, Stephan
Year 2017
Title An alternative sterility assessment for parenteral drug products using isothermal microcalorimetry
Journal Journal of Applied Microbiology
Volume 123
Number 3
Pages / Article-Number 773-779
Abstract Production and release of injectable drug solutions are highly regulated since the administration of injectables bypasses natural body barriers. The sterility test is the last opportunity of product quality assessment. However, sterility is currently assessed by visual inspection (VI) that is time consuming and somewhat subjective. Therefore, we assessed isothermal microcalorimetry (IMC) as a replacement for the VI of the filtration based state-of-the-art sterility control.; We used ATCC strains and house isolates to artificially contaminate frequently produced monoclonal antibodies (Avastin, Mabthera, Herceptin). After filtration, growth was assessed with IMC. Growth of all micro-organisms was reliably and reproducibly detected 4 days after inoculation, which was significantly faster than with VI.; The reliability and the sensitivity of IMC have a large potential to improve sterility controls. Further evaluation of this alternative method is therefore highly recommended.; Drug safety is of great concern for public health. Faster and safer drug production could be achieved using the technique described here. All the tests were performed with real manufactured drugs and complied with pharmaceutical standards. This suggests that drug sterility testing can be improved with potentially increased safety and cost reduction.
Publisher WILEY
ISSN/ISBN 1364-5072 ; 1365-2672
edoc-URL https://edoc.unibas.ch/59258/
Full Text on edoc No
Digital Object Identifier DOI 10.1111/jam.13520
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/28776899
ISI-Number WOS:000407808100019
Document type (ISI) Article
 
   

MCSS v5.8 PRO. 0.397 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
25/04/2024